Buprenorphine – A First Line Consideration for Pain Management in Serious Illness

Name: Buprenorphine – A First Line Consideration for Pain Management in Serious Illness
Start: 2026-09-02T13:30:00-04:00
End: 2026-09-02T16:45:00-04:00

Wednesday, September 2, 2026
1:30 pm to 4:45 pm

Dartmouth Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756
Jack Byrne Center or attend virtually

Registration required

There is no fee to register for this program, but advance registration is required for planning purposes.

The registration deadline is 1 week prior to the activity date.

Overview

In this 3-hour hybrid interactive course, clinicians caring for people with serious illness will learn about the different formulations of buprenorphine used for pain management as well as for opioid use disorder. Clinicians will apply their knowledge about the pharmacology of buprenorphine to discuss applications for use in the hospital, ambulatory and end-of-life care settings through the use of interactive case-based discussions.

Accreditation

Please see the event registration site for accreditation information.